Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Uldrick Website

Thomas S. Uldrick, M.D.

Selected Publications

1)  Venkataraman G, Uldrick TS, Aleman K, O'Mahony D, Karcher DS, Steinberg SM, Raffeld MA, Marshall V, Whitby D, Little RF, Yarchoan R, Pittaluga S, Maric I.
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Am. J. Clin. Pathol. 139: 651-61, 2013.
[Journal]
2)  Uldrick TS, Pipkin S, Scheer S, Hessol NA.
Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
AIDS. 2013.
[Journal]
3)  Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V, Pittaluga S, O'Mahony D, Whitby D, Tosato G, Steinberg SM, Little RF, Yarchoan R.
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Blood. 2013.
[Journal]
4)  Dong HY, Wang W, Uldrick TS, Gangi M.
Human herpesvirus 8- and Epstein-Barr virus-associated solitary B cell lymphoma with a T cell immunophenotype.
Leuk. Lymphoma. 54: 1560-3, 2013.
[Journal]
5)  de Witt P, Maartens DJ, Uldrick TS, Sissolak G.
Treatment outcomes in AIDS-related diffuse large B-cell lymphoma in the setting roll out of combination antiretroviral therapy in South Africa.
J. Acquir. Immune Defic. Syndr. 64: 66-73, 2013.
[Journal]
6)  Mosam A, Shaik F, Uldrick TS, Esterhuizen T, Friedland GH, Scadden DT, Aboobaker J, Coovadia HM.
A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
J. Acquir. Immune Defic. Syndr. 60: 150-7, 2012.
[Journal]
7)  Uldrick TS, Wyvill KM, Kumar P, O'Mahony D, Bernstein W, Aleman K, Polizzotto MN, Steinberg SM, Pittaluga S, Marshall V, Whitby D, Little RF, Yarchoan R.
Phase II study of bevacizumab in patients with HIV-associated Kaposi"s sarcoma receiving antiretroviral therapy.
J. Clin. Oncol. 30: 1476-83, 2012.
[Journal]
8)  Mosam A, Uldrick TS, Shaik F, Carrara H, Aboobaker J, Coovadia H.
An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa.
Int J STD AIDS. 22: 671-3, 2011.
[Journal]
9)  Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA.
Cancer burden in the HIV-infected population in the United States.
J. Natl. Cancer Inst. 103: 753-62, 2011.
[Journal]
10)  Uldrick TS, Polizzotto MN, Aleman K, O'Mahony D, Wyvill KM, Wang V, Marshall V, Pittaluga S, Steinberg SM, Tosato G, Whitby D, Little RF, Yarchoan R.
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Blood. 117: 6977-86, 2011.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 11/25/2013.